# A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

> **NCT00002168** · NA · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 200 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Indinavir sulfate
- **DRUG:** Lamivudine
- **DRUG:** Stavudine
- **DRUG:** Zidovudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00002168
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (—)
- **Last updated:** 2007-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002168, "A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00002168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*